Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Feb 21, 2025, 4:00 PM
1.260
-0.030 (-2.33%)
After-hours: Feb 21, 2025, 7:45 PM EST
Clearmind Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Feb '25 Feb 21, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 |
Market Capitalization | 6 | 6 | 2 | 10 | 22 | - | |
Market Cap Growth | 216.00% | 216.00% | -82.89% | -53.14% | - | - | |
Enterprise Value | -1 | -2 | -2 | 10 | 17 | - | |
Last Close Price | 1.29 | 1.39 | 3.66 | 237.00 | 533.61 | - | |
PB Ratio | 1.77 | 1.81 | 1.81 | -9.43 | 4.63 | - | |
P/TBV Ratio | 1.88 | 1.88 | 2.06 | - | 4.83 | - | |
Debt / Equity Ratio | 0.02 | 0.02 | - | -0.03 | - | - | |
Quick Ratio | 1.70 | 1.70 | 1.16 | 0.22 | 13.33 | 24.92 | |
Current Ratio | 1.72 | 1.72 | 1.17 | 0.22 | 13.78 | 24.92 | |
Return on Equity (ROE) | -256.89% | -256.89% | - | -570.96% | -145.26% | -182.13% | |
Return on Assets (ROA) | -54.37% | -54.37% | -116.22% | -169.53% | -83.90% | -100.94% | |
Return on Capital (ROIC) | -173.28% | -173.28% | - | -318.49% | -89.97% | -113.83% | |
Earnings Yield | -95.50% | -93.20% | -483.16% | -66.13% | -16.72% | - | |
FCF Yield | -88.31% | -86.17% | -353.17% | -35.78% | -12.89% | - | |
Buyback Yield / Dilution | -1431.07% | -1431.07% | -367.25% | -40.19% | -70.50% | -47.00% | |
Total Shareholder Return | -1431.07% | -1431.07% | -367.25% | -40.19% | -70.50% | -47.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.